Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

604 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
US health care: entitlement or privilege?
Kereiakes DJ, Willerson JT. Kereiakes DJ, et al. Circulation. 2004 Mar 30;109(12):1460-2. doi: 10.1161/01.CIR.0000124795.36864.78. Circulation. 2004. PMID: 15051650 No abstract available.
Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet Glycoprotein IIb/IIIa receptor blockade with oral xemilofiban: results of a multicenter, placebo-controlled, randomized trial.
Kereiakes DJ, Kleiman NS, Ferguson JJ, Masud AR, Broderick TM, Abbottsmith CW, Runyon JP, Anderson LC, Anders RJ, Dreiling RJ, Hantsbarger GL, Bryzinski B, Topol EJ. Kereiakes DJ, et al. Circulation. 1998 Sep 29;98(13):1268-78. doi: 10.1161/01.cir.98.13.1268. Circulation. 1998. PMID: 9751674 Clinical Trial.
The fire that burns within: C-reactive protein.
Kereiakes DJ. Kereiakes DJ. Circulation. 2003 Jan 28;107(3):373-4. doi: 10.1161/01.cir.0000053942.27259.ba. Circulation. 2003. PMID: 12551855 No abstract available.
Stem cells: the chameleon fountain of youth.
Kereiakes DJ. Kereiakes DJ. Circulation. 2003 Feb 25;107(7):939-40. doi: 10.1161/01.cir.0000057607.03836.f8. Circulation. 2003. PMID: 12600903 Review. No abstract available.
Vascular brachytherapy boon or bust?
Kereiakes DJ, Willerson JT. Kereiakes DJ, et al. Circulation. 2003 Jul 29;108(4):389-90. doi: 10.1161/01.CIR.0000084892.95826.0A. Circulation. 2003. PMID: 12885732 Review. No abstract available.
Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results.
Kereiakes DJ, Szyniszewski AM, Wahr D, Herrmann HC, Simon DI, Rogers C, Kramer P, Shear W, Yeung AC, Shunk KA, Chou TM, Popma J, Fitzgerald P, Carroll TE, Forer D, Adelman DC. Kereiakes DJ, et al. Circulation. 2003 Sep 16;108(11):1310-5. doi: 10.1161/01.CIR.0000087602.91755.19. Epub 2003 Aug 25. Circulation. 2003. PMID: 12939212 Clinical Trial.
604 results